GRNA News and Press, GreenLight Biosciences Holdings PBC

GreenLight Biosciences Holdings PBC (GRNA) is expected to report for Q2 2023

LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced the closing of its previously announced merger with SW MergerCo, Inc. (“Merger Sub”) and SW ParentCo, I...

NEW YORK, NY / ACCESSWIRE / June 26, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Conformis, Inc. (NASDAQ:CFMS)'s sale t...

NEW YORK, NY / ACCESSWIRE / June 8, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: PDC Energy, Inc. (NASDAQ:PDCE)'s sal...

NEW YORK, NY / ACCESSWIRE / June 4, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Arlington Asset Investment Corp. (NYSE...

2023-05-30 08:03:53 ET GreenLight Biosciences ( NASDAQ: GRNA ) to be acquired by a group of buyers led by Fall Line Capital in an all-cash transaction valued at $45.5M. Fall Line, together with its affiliates, agreed that it would commence a tender offer to acquire all share...

LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that the Company has entered into a definitive agreement (the “Merger Agreement”) to be acquired by a gr...

2023-05-11 12:13:02 ET GreenLight Biosciences press release ( NASDAQ: GRNA ): Q1 GAAP EPS of -$0.19 beats by $0.08 . Revenue of $3.82M (+1369.2% Y/Y) beats by $3.32M . For further details see: GreenLight Biosciences  GAAP EPS of -$0.19 beats by $...

BOSTON, May 11, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences, PBC (Nasdaq: GRNA), a biotechnology company dedicated to making RNA products affordable and accessible for human health and agriculture, today reported operational highlights and financial results for the first quarter ended Ma...

BOSTON, April 12, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, today released its inaugural Sustainability Re...